InvestorsHub Logo
Followers 28
Posts 1440
Boards Moderated 0
Alias Born 12/18/2014

Re: pgsd post# 521251

Wednesday, 10/12/2022 11:34:44 AM

Wednesday, October 12, 2022 11:34:44 AM

Post# of 700057
You’ve already gotten a few good replies to your post. My two cents I think “personalized ” is a bit of a stretch. Perhaps they will have different versions of the mRNA vaccine depending on the patient. But, as a MRK shareholder this is one of the avenues I expect them to explore (and hope for success) as they exhaust all relatively “off the shelf“ solutions before pursuing autologous personalized solution. IMO there is likely a place for both solutions depending on the cancer targeted.

Recovering former moderator.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News